Letters NICE on non-alcoholic fatty liver disease (NAFLD)

Authors’ reply to Tavabie

BMJ 2016; 355 doi: https://doi.org/10.1136/bmj.i5436 (Published 11 October 2016) Cite this as: BMJ 2016;355:i5436
  1. Chris Day, professor of liver medicine and honorary consultant hepatologist1,
  2. Jessica Glen, senior research fellow2,
  3. Lefteris Floros, senior health economist2,
  4. Rachel Pryke, general practitioner partner3
  1. 1Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne NE2 4HH, UK
  2. 2National Guideline Centre, Royal College of Physicians, London NW1 4LE, UK
  3. 3Winyates Health Centre, Redditch B98 0NR, UK
  1. chris.day{at}ncl.ac.uk

In response to the letter from Tavabie,1 2 we chose the 10.51 cut-off for the enhanced liver fibrosis (ELF) test because of the higher quality of evidence available for this threshold than for two others (low quality versus very low …

View Full Text

Sign in

Log in through your institution

Subscribe